• Jiao-tai-wan and Coptisine Target SIRT1 Ubiquitination in PC

  2026-05-06

  This study uncovers how Jiao-tai-wan (JTW) and its bioactive component coptisine ameliorate polycystic ovary syndrome (PCOS) by inhibiting SIRT1 ubiquitination and modulating mitochondrial cholesterol import in theca cells. The findings provide mechanistic clarity for traditional herbal interventions and suggest new experimental routes for dissecting ovarian steroidogenesis.

• AG-221 (Enasidenib): Reliable IDH2 Inhibition in AML Researc

  2026-05-05

  This article delivers a scenario-driven, evidence-based guide for biomedical researchers using AG-221 (Enasidenib, SKU B7804) in acute myeloid leukemia workflows. It addresses common laboratory challenges—such as assay reproducibility, metabolic resistance, and product selection—while grounding all recommendations in current literature and validated product specifications.

• SEMA3E Drives Beige Adipocyte Thermogenesis via β-Catenin in

  2026-05-05

  This study reveals that SEMA3E, a class 3 semaphorin, promotes beige adipocyte differentiation and thermogenic gene expression in mice by modulating β-catenin signaling. These findings provide mechanistic insight into adipose tissue plasticity and highlight new targets for metabolic and lipid metabolism research.

• LY364947: Applied TGF-β Type I Receptor Kinase Inhibitor Use

  2026-05-04

  LY364947 empowers researchers to dissect and precisely modulate the TGF-β signaling pathway, unlocking advanced experimental designs in EMT, fibrosis, and retinal degeneration studies. Its high selectivity and robust in vitro and in vivo performance make it a gold-standard tool for investigating cellular transitions and pathway crosstalk.

• Indomethacin in Inflammation Research: Applied Protocols & T

  2026-05-04

  Indomethacin offers researchers a Cox-1 selective approach to dissecting inflammation and lipid metabolism, with unique capabilities for membrane signaling modulation. This article delivers validated, stepwise protocols, advanced troubleshooting, and a practical translation of recent mechanistic findings to maximize reproducibility and insight in bench workflows.

• Digestive Metabolomics of Withania somnifera: LC-MS/MS Insig

  2026-05-03

  This study advances the pharmacological understanding of Withania somnifera by profiling the digestive transformations of its bioactive compounds using LC-MS/MS and molecular networking. The findings highlight the compound- and matrix-specific stability of withanolides under simulated gastrointestinal conditions, informing preclinical modeling of botanical extracts.

• Indomethacin in Inflammation Research: Applied Workflows & T

  2026-05-02

  Indomethacin stands out as a Cox-1 selective nonsteroidal anti-inflammatory drug, enabling precise dissection of inflammatory and lipid metabolic pathways. This guide delivers actionable protocols, advanced troubleshooting, and comparative insights for maximizing experimental success in cell and membrane signaling studies.

• Proteinase K: Precision Proteolysis for DNA Integrity in Res

  2026-05-01

  Proteinase K is a broad-spectrum serine protease with robust protein hydrolysis activity, widely used to improve DNA integrity during sample preparation. Its recombinant expression and resistance to common inhibitors support reliable genomic workflows. APExBIO’s K1037 formulation delivers high activity and workflow stability.

• GW4064 in FXR Signaling: Mechanistic Precision & Translation

  2026-05-01

  Explore GW4064, a potent non-steroidal FXR agonist, in unprecedented scientific depth. This article uniquely dissects its molecular mechanism and practical boundaries in FXR activation for metabolic research, drawing new insights from primary literature.

• 1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine in Src Kinase S

  2026-04-30

  1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine (PP 3) stands out as a rigorously validated negative control for Src kinase inhibition, enabling specificity and reproducibility in cell signaling research. See how APExBIO's PP 3 empowers precise validation, robust troubleshooting, and advanced applications in kinase pathway workflows.

• SARS-CoV-2 N Protein Disrupts GADD34-Mediated Innate Immunit

  2026-04-30

  Liu et al. reveal that the SARS-CoV-2 nucleocapsid protein disrupts the host innate immune pathway by sequestering GADD34 mRNA into atypical stress granule-like foci, impairing interferon responses. This mechanistic insight advances our understanding of viral immune evasion and provides a foundation for future research targeting host-pathogen interactions.

• Rhodamine B: Precision Fluorescent Probe for Drift & Cell As

  2026-04-29

  Rhodamine B (Basic Violet 10) stands out for its high solubility and robust fluorescence, enabling unmatched sensitivity in both pesticide drift tracing and advanced cell labeling workflows. Discover optimized protocols, troubleshooting strategies, and comparative insights that make APExBIO's Rhodamine B a benchmark for reproducible results across environmental and bioanalytical assays.

• OM-MSCs Mitigate Golgi Stress via PEDF-PI3K/Akt/mTOR After S

  2026-04-29

  This study elucidates how olfactory mucosa mesenchymal stem cells (OM-MSCs) alleviate Golgi apparatus stress responses following cerebral ischemia/reperfusion injury through activation of the PEDF-PI3K/Akt/mTOR pathway. The findings clarify a mechanistic link between OM-MSC therapy and neuroprotection, highlighting potential research avenues for modulating subcellular stress in stroke models.

• ABT-737: A Potent BCL-2 Protein Inhibitor for Apoptosis Indu

  2026-04-28

  ABT-737 is a selective, small molecule BCL-2 protein inhibitor with high potency in inducing apoptosis in cancer cells. It disrupts anti-apoptotic BCL-2 family protein interactions to trigger mitochondrial apoptosis, with demonstrated efficacy across lymphoma, multiple myeloma, SCLC, and AML models. Preclinical data highlight its value for targeted research in hematologic malignancies.

• Gallein: G Protein βγ Subunit Inhibitor for Translational Wo

  2026-04-28

  Gallein empowers researchers to dissect G protein βγ subunit signaling and precisely modulate GPCR pathways across cancer, immune, and cardiometabolic models. This guide delivers evidence-based protocols, troubleshooting strategies, and actionable insights to maximize reproducibility and data clarity with APExBIO's trusted inhibitor.

15718 records 1/1048 page Next 12345 下5页 Last page